Metabolic Heterogeneity Evidenced by MRS among Patient-Derived Glioblastoma Multiforme Stem-Like Cells Accounts for Cell Clustering and Different Responses to Drugs

<div>Analysis of the effects induced by oligomycin treatment. Confocal microscopy images and ML signal region from 1D 1H MR spectra of control and oligomycin-treated GSC lines #61, #74, #1, and #163.</div>

Stem Cells International

fig5

Figure 5

Figure 5: Metabolic Heterogeneity Evidenced by MRS among Patient-Derived Glioblastoma Multiforme Stem-Like Cells Accounts for Cell Clustering and Different Responses to Drugs 

Figure 5 | Metabolic Heterogeneity Evidenced by MRS among Patient-Derived Glioblastoma Multiforme Stem-Like Cells Accounts for Cell Clustering and Different Responses to Drugs 